Cilostazol for secondary stroke prevention: systematic review and meta-analysis

BACKGROUND: Stroke is one of the leading causes of death worldwide. Cilostazol, an antiplatelet and phosphodiesterase 3 inhibitor, has not been clearly established for ischaemic stroke use. We aim to determine the efficacy and safety of cilostazol for secondary stroke prevention. METHODS: MEDLINE, E...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Choon Han, Wu, Andrew GR, Sia, Ching-Hui, Leow, Aloysius ST, Chan, Bernard PL, Sharma, Vijay Kumar, Yeo, Leonard LL, Tan, Benjamin YQ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485237/
https://www.ncbi.nlm.nih.gov/pubmed/33542092
http://dx.doi.org/10.1136/svn-2020-000737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485237/
https://www.ncbi.nlm.nih.gov/pubmed/33542092
http://dx.doi.org/10.1136/svn-2020-000737

Ejemplares similares